GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Other Current Liabilities

NeoImmuneTech (XKRX:950220) Other Current Liabilities : ₩8,852.72 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Other Current Liabilities?

NeoImmuneTech's other current liabilities for the quarter that ended in Dec. 2023 was ₩8,852.72 Mil.

NeoImmuneTech's quarterly other current liabilities increased from Jun. 2023 (₩6,683.28 Mil) to Sep. 2023 (₩8,931.95 Mil) but then declined from Sep. 2023 (₩8,931.95 Mil) to Dec. 2023 (₩8,852.72 Mil).

NeoImmuneTech's annual other current liabilities declined from Dec. 2021 (₩17,554.58 Mil) to Dec. 2022 (₩13,038.14 Mil) and declined from Dec. 2022 (₩13,038.14 Mil) to Dec. 2023 (₩8,852.72 Mil).


NeoImmuneTech Other Current Liabilities Historical Data

The historical data trend for NeoImmuneTech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Other Current Liabilities Chart

NeoImmuneTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - - -

NeoImmuneTech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NeoImmuneTech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


NeoImmuneTech Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of NeoImmuneTech's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoImmuneTech (XKRX:950220) Business Description

Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines